BOSTON, Oct. 8, 2025 /PRNewswire/ -- eschbach, developer of Shiftconnector®, an intelligent operations platform for the pharmaceutical industry, has won the prestigious Pharmaceutical Technology Excellence Award —in two categories: for their innovation in operating intelligence with real-time visualization and the launch of collaborative AI features. 

eschbach is pleased to announce that to have been recognized with two awards in the 2025 Pharmaceutical Technology Excellence Awards—one of the industry's most prestigious global recognition programs. This includes the Innovation Award for Operational Intelligence and the Product Launches Award for the integration of eschbach's AI assistant, SAMI, into the Shiftconnector® platform.

"We are honored to be recognized in not only one, but two categories within the pharmaceutical technology industry. This is a testament to the incredible work everyone at eschbach has put into Shiftconnector® and will serve as further motivation to grow and push the boundaries on what software can do in manufacturing," said Andreas Eschbach, Founder and CEO of eschbach.

These awards highlight the progress that eschbach has made in transforming how pharmaceutical plants manage and act on data in real time. In today's reindustrializing pharmaceutical landscape, the ability to turn fragmented data into timely, compliant decisions is now essential to success.

Shiftconnector® is an operational intelligence platform that brings together structured data from systems like MES, LIMS, SCADA, and ERP, alongside critical unstructured context such as operator logs, shift handovers, and deviation records. By unifying these data sources, it provides plants with a complete, contextualized operational view—turning information into action.

The Shiftconnector® Tier Collaboration Dashboards (Tier Boards) allow every role—from frontline operators to site leadership—to access real-time, role-specific insights. This not only speeds up decision-making but also ensures compliance, consistency, and accountability across shifts. The result is an environment where teams can focus on the right issues quickly, reduce downtime, and sustain alignment in daily operations.

SAMI, the Shiftconnector® Artificial Manufacturing Intelligence assistant, is embedded directly into Shiftconnector®, bringing context-aware analytics into workflows. As an agentic AI tool with capabilities like Smart Search, Smart Solutions, and conversational Chat with SAMI, teams can surface insights, identify root causes, and resolve issues faster—all without leaving the platform. This integration marks a step forward in making AI a practical, everyday tool for pharmaceutical manufacturing teams worldwide.

About eschbach
With its global headquarters in Bad Säckingen, Germany and its North America headquarters in Boston, MA, eschbach is the premier enterprise software developer for the pharmaceutical and other process industries. Shiftconnector®, our award-winning solution, goes beyond shift communication. It enables real-time collaboration, effective handovers, and transparent reporting to enhance safety, compliance, and asset performance. With built-in KPI tracking, teams can monitor performance trends, identify bottlenecks, and drive continuous improvement. For nearly 20 years, leading companies like BASF, Bayer, and Roche have trusted Shiftconnector® to seamlessly unify people and processes across complex production environments.

For more information, visit www.eschbach.com

Media Contact - North America
Dawn Fontaine
Ripple Effect Communications
T: 617-536-8887
dawn@rippleeffectpr.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/eschbach-awarded-two-honors-in-the-2025-pharmaceutical-technology-excellence-awards-for-innovations-in-pharmaceutical-manufacturing-302579012.html

SOURCE eschbach